プロモーションスケジュール NeuBase Therapeutics, Inc.
詳細なスケジュール
簡易グラフ
会社について NeuBase Therapeutics, Inc.
NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. さらに詳しくIPO date | 2007-05-01 |
---|---|
ISIN | US64132K1025 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.neubasetherapeutics.com |
Цена ао | 0.378 |
1日あたりの価格変動: | -0% (0.378) |
---|---|
週ごとの価格変動: | -0% (0.378) |
月ごとの料金変更: | -0% (0.378) |
3ヶ月間の価格変動: | -0% (0.378) |
半年間の価格変動: | -0% (0.378) |
年間の価格変動: | -57.77% (0.895) |
3年間の価格推移: | -71.58% (1.33) |
5年間の価格推移: | -94.05% (6.35) |
10年間の価格推移: | -0% (0.378) |
年初からの価格変動: | -0% (0.378) |
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
機関 | 音量 | 共有, % |
---|---|---|
Greenlight Capital, Inc. | 136350 | 3.63 |
UBS Group AG | 65724 | 1.75 |
Point72 Asset Management, L.P. | 62500 | 1.67 |
Renaissance Technologies, LLC | 56967 | 1.52 |
Carnegie Mellon University | 46970 | 1.25 |
Two Sigma Investments, LP | 21083 | 0.56 |
Vanguard Group Inc | 18981 | 0.51 |
Kestra Advisory Services, LLC | 16476 | 0.44 |
Jacob Asset Management Of New York LLC | 15655 | 0.42 |
Prelude Capital Management LLC | 15550 | 0.41 |
スーパーバイザー | 役職 | 支払い | 生年 |
---|---|---|---|
Dr. Dietrich A. Stephan Ph.D. | Founder, President & Director | 836.58k | 1970 (55 年) |
Mr. Todd P. Branning | Interim CEO, CFO & Secretary | 427.44k | 1970 (55 年) |
住所: United States, Pittsburgh. PA, 350 Technology Drive - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.neubasetherapeutics.com
Webサイト: https://www.neubasetherapeutics.com